Masimo CEO Joe Kiani accepts award at the Texas Society for Respiratory Care's
36th Annual Meeting and Exposition in Austin, Texas.
Irvine, California June 28, 2007 - Masimo, the
inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion
pulse oximetry, today received the first ever Texas Society for
Respiratory Care (TSRC) LoneStar Award for Innovation and Support "for
the groundbreaking innovation of Rainbow SET Technology, and the
continued unwavering support of the TSRC and the Respiratory Care
profession." Masimo Chairman and CEO, Joe Kiani, accepted the award on
behalf of Masimo employees worldwide at the TSRC's 36th Annual Meeting
and Exhibition in Austin, Texas.
"Masimo has advanced patient care with its read-through motion pulse
oximetry technology, Masimo SET, making pulse oximeters a clinically
useful tool," said TSRC President-Elect Terry Gilmore, MA, and RRT.
"With their introduction of Masimo Rainbow SET and with it the
noninvasive measurement of carboxyhemoglobin and methemoglobin, they
are again advancing patient care by allowing respiratory care
professionals to have a better understanding of the true oxygenation
status of their patients' blood." Gary Herrin, MBA, Executive
Director of the TSRC added that "we greatly appreciate Masimo's long
standing support of the Respiratory Care profession and the TSRC, and
we welcome the opportunity to enhance this partnership in patient care.
We encourage their development and implementation of further
groundbreaking technology"
"We are honored to receive this award from TSRC for the advances in
patient care made possible by Masimo technologies, and are happy that
respiratory care professionals continue to look to Masimo to help them
provide cost-effective quality cardiopulmonary patient care." Mr. Kiani
explained. "For nearly 20 years, we have been privileged to work
alongside so many dedicated respiratory care professionals who shared
our vision of always doing what is best for patient care. This award is
very meaningful to us because it comes from an organization and a group
of professionals we greatly admire."
About Masimo
Masimo develops innovative
monitoring technologies that significantly improve patient care-helping
solve "unsolvable" problems. In 1995, the company debuted Read-Through
Motion and Low Perfusion pulse oximetry, known as SET and with it
virtually eliminated false alarms and increased pulse oximetry's
ability to detect life-threatening events. More than 100 independent
clinical studies have confirmed that Masimo SET technology allows
clinicians to accurately monitor blood oxygen saturation in critical
care situations-establishing the technology as the "gold standard"
pulse oximetry and substantially contributing to improved patient
outcomes. In 2005 Masimo introduced Masimo Rainbow SET Pulse
CO-Oximetry, which, for the first time, noninvasively monitors the
level of carbon monoxide and methemoglobin in the blood, allowing early
detection and treatment of potentially life-threatening conditions.
Masimo, founded in 1989, has the mission of "Improving Patient Outcomes
and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites
and Applications." Additional information about Masimo and its products
may be found at www.masimo.com.
Contact:
Tom McCall
Masimo Corporation
949-297-7075
Masimo, SET, Signal Extraction Technology,
Radical, Radical-7, Rad57, APOD, and Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and
Applications are registered trademarks of Masimo Corp. ARM, Acoustic
Respiratory Monitoring, BiFi, Rainbow, SpCO, SpMet, SpHb and Pulse
CO-Oximeter are trademarks of Masimo Corp.